Easterly Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Easterly Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Sell	8,406 -130	-2%	-$17.6K	0.07%	179
2026 Q1	$1.09M	Hold	8,536	–	–	0.08%	116
2025 Q4	$1.04M	Hold	8,536	–	–	0.06%	152
2025 Q3	$855K	Sell	8,536 -5,000	-37%	-$450K	0.06%	158
2025 Q2	$1.12M	Sell	13,536 -9,825	-42%	-$784K	0.08%	141
2025 Q1	$1.89M	Buy	23,361 +5,300	+29%	+$474K	0.16%	113
2024 Q4	$1.63M	Hold	18,061	–	–	0.13%	127
2024 Q3	$1.78M	Hold	18,061	–	–	0.14%	126
2024 Q2	$1.67M	Hold	18,061	–	–	0.15%	120
2024 Q1	$1.71M	Sell	18,061 -5,001	-22%	-$464K	0.13%	133
2023 Q4	$2.06M	Sell	23,062 -5,000	-18%	-$371K	0.22%	99
2023 Q3	$2.05M	Buy	28,062 +5,000	+22%	+$399K	0.23%	97
2023 Q2	$1.92M	Buy	23,062 +1,000	+5%	+$83.6K	0.17%	111
2023 Q1	$1.68M	Buy	22,062 +470	+2%	+$39K	0.15%	116
2022 Q4	$1.79M	Buy	21,592 +3,501	+19%	+$283K	0.15%	116
2022 Q3	$1.44M	Sell	18,091 -10,000	-36%	-$843K	0.14%	120
2022 Q2	$2.09M	Buy	28,091 +10,000	+55%	+$751K	0.19%	103
2022 Q1	$1.63M	Buy	+18,091	New	+$1.67M	0.12%	122

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Easterly Investment Partners's XBI Position: Q2 2026 in Review

Easterly Investment Partners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.5% in Q2 2026, selling an estimated $17.6K and leaving 8,406 shares worth $1.33M. The position accounts for 0.07% of the portfolio, ranked #179.

Easterly Investment Partners first reported a position in XBI in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.09M in Q2 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Easterly Investment Partners held 8,406 shares of State Street SPDR S&P Biotech ETF worth $1.33M as of Q2 2026.
Easterly Investment Partners sold 130 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $17.6K.
State Street SPDR S&P Biotech ETF made up 0.07% of Easterly Investment Partners's portfolio in Q2 2026, its #179 holding.
Easterly Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 18 quarters since.
Easterly Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $2.09M in Q2 2022.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Easterly Investment Partners's 13F filing for Q2 2026, filed 23 Jul 2026.